Your browser doesn't support javascript.
loading
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221.
Kotani, Ai; Ha, Daon; Hsieh, James; Rao, Prakash K; Schotte, Diana; den Boer, Monique L; Armstrong, Scott A; Lodish, Harvey F.
Affiliation
  • Kotani A; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Blood ; 114(19): 4169-78, 2009 Nov 05.
Article in En | MEDLINE | ID: mdl-19749093
ABSTRACT
MLL-AF4 acute lymphocytic leukemia (ALL) has a poor prognosis. MicroRNAs (miRNA) are small noncoding RNAs that posttranscriptionally regulate expression of target mRNAs. Our analysis of previously published data showed that expression of miR-128b and miR-221 is down-regulated in MLL-rearranged ALL relative to other types of ALL. Reexpression of these miRNAs cooperatively sensitizes 2 cultured lines of MLL-AF4 ALL cells to glucocorticoids. Target genes down-regulated by miR-128b include MLL, AF4, and both MLL-AF4 and AF4-MLL fusion genes; miR-221 down-regulates CDKN1B. These results demonstrate that down-regulation of miR-128b and miR-221 is implicated in glucocorticoid resistance and that restoration of their levels is a potentially promising therapeutic in MLL-AF4 ALL.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Neoplasm / Oncogene Proteins, Fusion / MicroRNAs / Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Blood Year: 2009 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Neoplasm / Oncogene Proteins, Fusion / MicroRNAs / Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans Language: En Journal: Blood Year: 2009 Document type: Article Affiliation country: Estados Unidos